ETUDE | PHASE | SITE |
---|---|---|
EF-32: Pivotal, Randomized, Open-Label Study of Optune® (Tumor Treating Fields, 200kHz) Concomitant With Radiation Therapy and Temozolomide for the Treatment of Newly Diagnosed Glioblastoma
Glioblastoma Multiforme
|
autre
|
CHUV
|
IMA950-106 - Pembrolizumab in association with the Multipeptide vaccine IMA950 adjuvanted with Poly-ICLC for relapsing Glioblastoma: a randomized phase I/ II trial
Relapsing Glioblastoma
|
I, II
|
HUG
|
RESURGE: Randomized Controlled Comparative Phase II Trial on Surgery for Glioblastoma Recurrence
Gliobastome récidivant
|
II
|
CHUV
|